Vident Investment Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,255
| Closed | -$1.18M | – | 101 |
|
|
2023
Q2 | $1.18M | Buy |
8,255
+2,073
| +34% | +$305K | 0.04% | 436 |
|
|
2023
Q1 | $858K | Buy |
6,182
+1,528
| +33% | +$206K | 0.03% | 572 |
|
|
2022
Q4 | $631K | Sell |
4,654
-3,664
| -44% | -$459K | 0.02% | 634 |
|
|
2022
Q3 | $607K | Buy |
8,318
+192
| +2% | +$24.4K | 0.02% | 730 |
|
|
2022
Q2 | $1.07M | Sell |
8,126
-2,617
| -24% | -$343K | 0.03% | 597 |
|
|
2022
Q1 | $1.43M | Buy |
10,743
+1,932
| +22% | +$232K | 0.04% | 573 |
|
|
2021
Q4 | $1.03M | Sell |
8,811
-5,743
| -39% | -$676K | 0.03% | 695 |
|
|
2021
Q3 | $1.75M | Buy |
14,554
+1,283
| +10% | +$149K | 0.05% | 493 |
|
|
2021
Q2 | $1.59M | Sell |
13,271
-2,374
| -15% | -$260K | 0.05% | 496 |
|
|
2021
Q1 | $1.56M | Sell |
15,645
-705
| -4% | -$70.9K | 0.05% | 481 |
|
|
2020
Q4 | $1.64M | Buy |
16,350
+3,093
| +23% | +$328K | 0.07% | 366 |
|
|
2020
Q3 | $1.45M | Sell |
13,257
-205
| -2% | -$22.8K | 0.07% | 377 |
|
|
2020
Q2 | $1.42M | Sell |
13,462
-2,045
| -13% | -$211K | 0.07% | 345 |
|
|
2020
Q1 | $1.39M | Sell |
15,507
-616
| -4% | -$58K | 0.09% | 290 |
|
|
2019
Q4 | $1.61M | Sell |
16,123
-1,734
| -10% | -$163K | 0.1% | 315 |
|
|
2019
Q3 | $1.59M | Sell |
17,857
-358
| -2% | -$31K | 0.14% | 104 |
|
|
2019
Q2 | $1.5M | Sell |
18,215
-1,950
| -10% | -$153K | 0.12% | 120 |
|
|
2019
Q1 | $1.63M | Sell |
20,165
-43
| -0.2% | -$3.39K | 0.09% | 324 |
|
|
2018
Q4 | $1.53M | Sell |
20,208
-12,446
| -38% | -$972K | 0.09% | 316 |
|
|
2018
Q3 | $2.58M | Sell |
32,654
-1,891
| -5% | -$143K | 0.1% | 277 |
|
|
2018
Q2 | $2.43M | Buy |
34,545
+8,068
| +30% | +$580K | 0.1% | 285 |
|
|
2018
Q1 | $1.89M | Buy |
26,477
+7,724
| +41% | +$535K | 0.08% | 316 |
|
|
2017
Q4 | $1.3M | Buy |
18,753
+1,761
| +10% | +$119K | 0.06% | 334 |
|
|
2017
Q3 | $1.15M | Buy |
16,992
+515
| +3% | +$32.5K | 0.06% | 348 |
|
|
2017
Q2 | $1.12M | Sell |
16,477
-16
| -0.1% | -$1.04K | 0.09% | 311 |
|
|
2017
Q1 | $1.03M | Buy |
16,493
+3,164
| +24% | +$184K | 0.1% | 307 |
|
|
2016
Q4 | $728K | Buy |
13,329
+1,072
| +9% | +$60.9K | 0.09% | 308 |
|
|
2016
Q3 | $806K | Sell |
12,257
-62
| -0.5% | -$4.05K | 0.11% | 307 |
|
|
2016
Q2 | $744K | Sell |
12,319
-10,448
| -46% | -$607K | 0.1% | 300 |
|
|
2016
Q1 | $1.28K | Buy |
22,767
+10,863
| +91% | +$653K | 0.08% | 344 |
|
|
2015
Q4 | $808K | Buy |
+11,904
| New | +$780K | 0.1% | 330 |
|
Other funds holding AZN
